NFKB1 and glioblastoma: Specifically, it has been found that NFkB signalling in involved in the invasive properties of GBM via metalloproteinases, which can be deprecated with NFkB inhibition71, and that NFkB knockout mice exhibit decreased tumour growth and increased pro-inflammatory cytokines49.